Literature DB >> 18381643

Falls and gait disturbances in Huntington's disease.

Yvette A M Grimbergen1, Mirjam J Knol2, Bastiaan R Bloem2, Berry P H Kremer2, Raymund A C Roos1, Marten Munneke2.   

Abstract

Falls are common in patients with Huntington's disease, but the incidence, falling circumstances and contributing factors have never been examined. We recorded falls in 45 early to midstage Huntington's disease patients, both retrospectively (12 months) and prospectively (3 months). Fall rates were related to relevant baseline measures, including the Unified Huntington's Disease Rating Scale (UHDRS) and quantitative measures of balance (using angular velocity sensors) and gait (using a pressure-sensitive walkway). Balance and gait measures were compared between patients and 27 healthy age-matched controls. Twenty-seven patients (60%) reported two or more falls in the previous year and were classified as fallers. During prospective follow-up 40% reported at least one fall. A high proportion of falls (72.5%) caused minor injuries. Compared to nonfallers, fallers showed significantly higher scores for chorea, bradykinesia and aggression, as well as lower cognitive scores. Compared to controls, Huntington patients had a decreased gait velocity (1.15 m/s versus 1.45 m/s, P < 0.001) and a decreased stride length (1.29 m versus 1.52 m, P < 0.001). These abnormalities were all significantly greater in fallers compared to nonfallers. In addition, fallers had an increased stride length variability and a significantly greater trunk sway in medio-lateral direction compared to nonfallers. We conclude that falls are common in Huntington's disease. Contributing factors include a combination of "motor" deficits (mainly gait bradykinesia, stride variability and chorea, leading to excessive trunk sway), as well as cognitive decline and perhaps behavioral changes. These factors should be considered as future targets for therapies that aim to reduce falls in Huntington's disease.

Entities:  

Mesh:

Year:  2008        PMID: 18381643     DOI: 10.1002/mds.22003

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  40 in total

Review 1.  Therapy in Huntington's disease: where are we?

Authors:  Martha A Nance
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

2.  Kinematic measures for assessing gait stability in elderly individuals: a systematic review.

Authors:  D Hamacher; N B Singh; J H Van Dieën; M O Heller; W R Taylor
Journal:  J R Soc Interface       Date:  2011-08-31       Impact factor: 4.118

3.  Evidence-based guideline: pharmacologic treatment of chorea in Huntington disease: report of the guideline development subcommittee of the American Academy of Neurology.

Authors:  Melissa J Armstrong; Janis M Miyasaki
Journal:  Neurology       Date:  2012-07-18       Impact factor: 9.910

4.  Heart rate variability and falls in Huntington's disease.

Authors:  Daniel E Vigo; Marcelo Merello; Cinthia Terroba-Chambi; Veronica Bruno
Journal:  Clin Auton Res       Date:  2020-02-06       Impact factor: 4.435

5.  Perceptions of the impact of chorea on health-related quality of life in Huntington disease (HD): A qualitative analysis of individuals across the HD spectrum, family members, and clinicians.

Authors:  Carey Wexler Sherman; Ravi Iyer; Victor Abler; Alexandria Antonelli; Noelle E Carlozzi
Journal:  Neuropsychol Rehabil       Date:  2019-03-08       Impact factor: 2.868

6.  Patient-reported outcomes in Huntington's disease: Quality of life in neurological disorders (Neuro-QoL) and Huntington's disease health-related quality of life (HDQLIFE) physical function measures.

Authors:  Noelle E Carlozzi; Rebecca E Ready; Samuel Frank; David Cella; Elizabeth A Hahn; Siera M Goodnight; Stephen G Schilling; Nicholas R Boileau; Praveen Dayalu
Journal:  Mov Disord       Date:  2017-05-27       Impact factor: 10.338

7.  Huntington's disease (HD): degeneration of select nuclei, widespread occurrence of neuronal nuclear and axonal inclusions in the brainstem.

Authors:  Udo Rüb; Matthias Hentschel; Katharina Stratmann; Ewout Brunt; Helmut Heinsen; Kay Seidel; Mohamed Bouzrou; Georg Auburger; Henry Paulson; Jean-Paul Vonsattel; Herwig Lange; Horst-Werner Korf; Wilfred den Dunnen
Journal:  Brain Pathol       Date:  2014-03-03       Impact factor: 6.508

8.  High prevalence of vitamin D deficiency and insufficiency in patients with manifest Huntington disease: An explorative study.

Authors:  Victor Gm Chel; Marcel E Ooms; Jessie van der Bent; Fleur Veldkamp; Raymund Ac Roos; Wilco P Achterberg; Paul Lips
Journal:  Dermatoendocrinol       Date:  2013-08-15

9.  The development of a new computer adaptive test to evaluate chorea in Huntington disease: HDQLIFE Chorea.

Authors:  N E Carlozzi; N R Downing; S G Schilling; J-S Lai; S M Goodnight; J A Miner; S A Frank
Journal:  Qual Life Res       Date:  2016-05-03       Impact factor: 4.147

10.  Late onset Huntington Disease: clinical and genetic characteristics of 34 cases.

Authors:  Hillary Lipe; Thomas Bird
Journal:  J Neurol Sci       Date:  2008-10-31       Impact factor: 3.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.